Glaxosmithkline Plc Adrf's ticker is and the CUSIP is 832378301. A total of 1 filers reported holding Glaxosmithkline Plc Adrf in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $34,000 | -19.0% | 967 | 0.0% | 0.02% | -22.7% |
| Q2 2017 | $42,000 | +2.4% | 967 | 0.0% | 0.02% | -4.3% |
| Q1 2017 | $41,000 | +127.8% | 967 | +107.1% | 0.02% | +109.1% |
| Q4 2016 | $18,000 | -10.0% | 467 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $20,000 | +185.7% | 467 | +179.6% | 0.01% | +175.0% |
| Q2 2016 | $7,000 | -63.2% | 167 | -64.2% | 0.00% | -63.6% |
| Q1 2016 | $19,000 | 0.0% | 467 | 0.0% | 0.01% | +10.0% |
| Q4 2015 | $19,000 | +5.6% | 467 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $18,000 | -35.7% | 467 | -30.0% | 0.01% | -28.6% |
| Q2 2015 | $28,000 | -9.7% | 667 | 0.0% | 0.01% | -6.7% |
| Q1 2015 | $31,000 | +6.9% | 667 | 0.0% | 0.02% | +15.4% |
| Q4 2014 | $29,000 | -6.5% | 667 | 0.0% | 0.01% | -13.3% |
| Q3 2014 | $31,000 | -13.9% | 667 | 0.0% | 0.02% | -16.7% |
| Q2 2014 | $36,000 | 0.0% | 667 | 0.0% | 0.02% | -5.3% |
| Q1 2014 | $36,000 | 0.0% | 667 | 0.0% | 0.02% | 0.0% |
| Q4 2013 | $36,000 | +9.1% | 667 | 0.0% | 0.02% | +11.8% |
| Q3 2013 | $33,000 | 0.0% | 667 | 0.0% | 0.02% | 0.0% |
| Q2 2013 | $33,000 | – | 667 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 467 | $19,000 | 0.01% |